Dr. Reddy's Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RDY and other ETFs, options, and stocks.

About RDY

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. 

CEO
Erez Israeli
CEOErez Israeli
Employees
27,527
Employees27,527
Headquarters
Hyderabad, Telangana
HeadquartersHyderabad, Telangana
Founded
1984
Founded1984
Employees
27,527
Employees27,527

RDY Key Statistics

Market cap
10.87B
Market cap10.87B
Price-Earnings ratio
28.65
Price-Earnings ratio28.65
Dividend yield
0.50%
Dividend yield0.50%
Average volume
2.98M
Average volume2.98M
High today
$13.10
High today$13.10
Low today
$12.90
Low today$12.90
Open price
$13.05
Open price$13.05
Volume
2.29M
Volume2.29M
52 Week high
$15.67
52 Week high$15.67
52 Week low
$11.36
52 Week low$11.36

RDY News

MarketWatch 2d
Dr. Reddy's Laboratories rallies Thursday, underperforms competitors - MarketWatch

...

Dr. Reddy's Laboratories rallies Thursday, underperforms competitors - MarketWatch
TipRanks 3d
Dr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant

Dr Reddy’s Laboratories ( (RDY) ) has provided an update. The U.S. Food and Drug Administration completed a pre-approval inspection at Dr. Reddy’s FTO-9 manufa...

Analyst ratings

45%

of 40 ratings
Buy
45%
Hold
22.5%
Sell
32.5%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.